Differential Biofilm Susceptibility and Potent Isavuconazole Post-Antifungal Effect Distinguish Cutaneotrichosporon dermatis from Trichosporon asahii
- 1Kumamoto University
Abstract
Cutaneotrichosporon dermatis (formerly Trichosporon dermatis) is a basidiomycetous yeast-like fungus known to cause summer-type hypersensitivity pneumonitis, although its virulence in humans remains poorly understood. We performed morphological and molecular identification of an isolate from the sputum and blood cultures of an immunocompromised patient, together with pathogenicity assessment using a Galleria mellonella model, biofilm formation/eradication assays, antifungal susceptibility testing, drug combination effects, and the post-antifungal effect (PAFE), compared with Trichosporon asahii. The isolate was identified as C. dermatis by ITS/IGS1 sequencing, supported by phylogenetic analysis. Growth of C. dermatis increased more at 37 than at 25. In the Galleria mellonella assay, C. dermatis, T. asahii, and Candida albicans each showed dose-dependent pathogenicity at sufficiently high inocula, although Rhizopus oryzae was the most potent pathogen on a per-CFU basis. C. dermatis formed biofilms that were more completely inhibited by terbinafine (TRB) and amphotericin B (AmB) than azole agents, which showed only partial inhibitory activity even at high concentrations. Susceptibility testing showed relatively strong susceptibility to AmB and azole agents. In the TRB and azole combination assay, the fractional inhibitory concentration index (FICI) was below 0.5, indicating synergy. Isavuconazole (ISC) showed a markedly stronger PAFE than the other azole agents tested. These findings indicate that although azoles show only partial efficacy against its biofilm, C. dermatis can still cause invasive infection, and that azole monotherapy or TRB and azole combination therapy, aided by the potent PAFE of ISC, may represent effective treatment options.
Related
- Contrasting defensive strategies underlie differential susceptibility of corals to crown-of-thorns sea star (CoTS; Acanthaster cf. solaris ) predation
- Differential requirement for the Ire1 luminal domain in Candida albicans drug susceptibility and pathogenicity
- Dietary fiber-type-specific gut microbiome preconditioning drives differential susceptibility to sporadic colon cancer development
- Differential expression of NEAT1 in the corneal endothelium increases susceptibility to oxidative stress in Fuchs Endothelial Corneal Dystrophy
- Percussive manipulations distinguish object play in capuchin and patas monkeys
BibTeX
@misc{yoshinouchi2026differential,
title = {{Differential Biofilm Susceptibility and Potent Isavuconazole Post-Antifungal Effect Distinguish Cutaneotrichosporon dermatis from Trichosporon asahii}},
author = {T. Yoshinouchi and T. Nakamura and D. Mori and J.-i. Yasunaga and Y. Tanaka},
howpublished = {bioRxiv},
year = {2026},
month = aug,
doi = {10.64898/2026.08.30.748177},
url = {https://www.biorxiv.org/content/10.64898/2026.08.30.748177v1},
note = {CC BY},
}
RIS
TY - UNPB
TI - Differential Biofilm Susceptibility and Potent Isavuconazole Post-Antifungal Effect Distinguish Cutaneotrichosporon dermatis from Trichosporon asahii
AU - T. Yoshinouchi
AU - T. Nakamura
AU - D. Mori
AU - J.-i. Yasunaga
AU - Y. Tanaka
PY - 2026
DA - 2026/08/30
PB - bioRxiv
DO - 10.64898/2026.08.30.748177
UR - https://www.biorxiv.org/content/10.64898/2026.08.30.748177v1
AB - Cutaneotrichosporon dermatis (formerly Trichosporon dermatis) is a basidiomycetous yeast-like fungus known to cause summer-type hypersensitivity pneumonitis, although its virulence in humans remains poorly understood. We performed morphological and molecular identification of an isolate from the sputum and blood cultures of an immunocompromised patient, together with pathogenicity assessment using a Galleria mellonella model, biofilm formation/eradication assays, antifungal susceptibility testing, drug combination effects, and the post-antifungal effect (PAFE), compared with Trichosporon asahii. The isolate was identified as C. dermatis by ITS/IGS1 sequencing, supported by phylogenetic analysis. Growth of C. dermatis increased more at 37 than at 25. In the Galleria mellonella assay, C. dermatis, T. asahii, and Candida albicans each showed dose-dependent pathogenicity at sufficiently high inocula, although Rhizopus oryzae was the most potent pathogen on a per-CFU basis. C. dermatis formed biofilms that were more completely inhibited by terbinafine (TRB) and amphotericin B (AmB) than azole agents, which showed only partial inhibitory activity even at high concentrations. Susceptibility testing showed relatively strong susceptibility to AmB and azole agents. In the TRB and azole combination assay, the fractional inhibitory concentration index (FICI) was below 0.5, indicating synergy. Isavuconazole (ISC) showed a markedly stronger PAFE than the other azole agents tested. These findings indicate that although azoles show only partial efficacy against its biofilm, C. dermatis can still cause invasive infection, and that azole monotherapy or TRB and azole combination therapy, aided by the potent PAFE of ISC, may represent effective treatment options.
ER -